Current ratio spoločnosti Ayala Pharmaceuticals
Aká je hodnota metriky Current ratio spoločnosti Ayala Pharmaceuticals?
Hodnota metriky Current ratio spoločnosti Ayala Pharmaceuticals Inc. je 0.53
Aká je definícia metriky Current ratio?
Current ratio je ukazovateľ likvidity, ktorý meria či má spoločnosť dostatok zdrojov na splnenie svojich krátkodobých záväzkov.
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Ayala Pharmaceuticals
Čomu sa venuje spoločnosť Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Firmy s metrikou current ratio podobnou spoločnosti Ayala Pharmaceuticals
- Hodnota metriky Current ratio spoločnosti The Tinley Beverage Co je 0.53
- Hodnota metriky Current ratio spoločnosti Orange Belgium S.A je 0.53
- Hodnota metriky Current ratio spoločnosti Western Asset Premier Bond Fund je 0.53
- Hodnota metriky Current ratio spoločnosti Investis SA je 0.53
- Hodnota metriky Current ratio spoločnosti Linedata Services S.A je 0.53
- Hodnota metriky Current ratio spoločnosti Orsu Metals je 0.53
- Hodnota metriky Current ratio spoločnosti Ayala Pharmaceuticals je 0.53
- Hodnota metriky Current ratio spoločnosti PTL Enterprises je 0.53
- Hodnota metriky Current ratio spoločnosti Vital je 0.53
- Hodnota metriky Current ratio spoločnosti Williamson Magor & Co je 0.54
- Hodnota metriky Current ratio spoločnosti Shiloh Industries je 0.54
- Hodnota metriky Current ratio spoločnosti Shiloh Industries je 0.54
- Hodnota metriky Current ratio spoločnosti Jetblue Airways Corp je 0.54